Commit To Buy Avalanche Biotechnologies At $5, Earn 20.3% Annualized Using Options

Investors eyeing a purchase of Avalanche Biotechnologies, Inc. (AAVL) shares, but cautious about paying the going market price of $6.20/share, might benefit from considering selling puts among the alternative strategies at their disposal..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.